Sangamo Therapeutics, Inc. (0R1D.L)
LSE - LSE Delayed Price. Currency in USD
Add to watchlist
As of 02:34PM BST. Market open.
| Previous Close | 0.5228 |
| Open | 0.5250 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's Range | 0.5250 - 0.5399 |
| 52 Week Range | 0.2900 - 2.1105 |
| Volume | |
| Avg. Volume | 47,193 |
| Market Cap | 655,061 |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.2130 |
| Earnings Date | Aug 06, 2024 - Aug 12, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ZacksSangamo Therapeutics (SGMO) Reports Q1 Loss, Lags Revenue Estimates
Sangamo (SGMO) delivered earnings and revenue surprises of -22.73% and 94.35%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Business WireSangamo Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial Results
RICHMOND, Calif., May 09, 2024--SANGAMO THERAPEUTICS REPORTS RECENT BUSINESS HIGHLIGHTS AND FIRST QUARTER 2024 FINANCIAL RESULTS
Business WireSangamo Therapeutics Presents Next-Generation Modular Integrase Technology Engineered to Enable Large-Scale Genome Editing
RICHMOND, Calif., May 09, 2024--Sangamo Therapeutics Presents Next-Generation Modular Integrase Technology Engineered to Enable Large-Scale Genome Editing
© 2024 Yahoo. All rights reserved.